Le Lézard
Classified in: Health, Covid-19 virus
Subject: CFG

Statement on the Omicron variant of concern found in Ontario

OTTAWA, ON, Nov. 28, 2021 /CNW/ - The Government of Canada has a monitoring program in place with the provinces and territories to identify new COVID-19 variants in Canada, such as the Omicron variant of concern.

Genomic sequencing is an integral part of Canada's ongoing response to COVID-19 to track natural evolution of the virus, including its variants. Provinces and territories, as well as the Public Health Agency of Canada's (PHAC) National Microbiology Laboratory, monitor Canadian cases of COVID-19 through ongoing analysis of genomic databases in Canada. This monitoring work, including border surveillance, has confirmed two cases of the Omicron variant of concern in Ontario.

As the monitoring continues, it is expected that other cases of this variant will be found in Canada and other countries. Canadians are reminded that vaccination, in combination with public health and individual protective measures, is working to reduce the spread of COVID-19 and its variants in our communities.

To reduce the risk of importation of the virus and any of its variants, Canada has had travel restrictions and border measures in place since March 2020. These rigorous quarantine and testing measures are among some of the strongest in the world.

On November 26, in response to concerns about the Omicron variant of concern, the Government of Canada swiftly implemented enhanced border measures for all travellers who have been in the Southern Africa region ? including South Africa, Eswatini, Lesotho, Botswana, Zimbabwe, Mozambique, and Namibia ? within the last 14 days before arriving in Canada, until January 31, 2022.

Early data suggest that the Omicron variant may be more transmissible but evidence is limited at this time. There is ongoing international data gathering to determine the impact of this variant on severity of illness and on vaccine effectiveness. These temporary border measures are being implemented while the Canadian and global medical, public health and research communities actively evaluate this variant ? as has been done with previous variants -- to understand the potential implications in terms of transmission, clinical presentation and vaccine efficacy.

The Government of Canada advises Canadians to avoid travelling to countries in the Southern African region and will continue to monitor the situation to inform current or future actions. Restrictions are changing quickly and may be imposed by countries with little warning, disrupting travel plans. Should individuals choose to travel outside Canada, they may be forced to remain outside of Canada longer than expected.

Canada continues to maintain pre-entry molecular testing for vaccinated and unvaccinated international travellers arriving from any country to reduce the risk of importation of COVID-19 including variants.

The Government of Canada will continue to assess the evolving situation and adjust border measures as required. Canadians are reminded that vaccination, in combination with public health and individual measures, is just as important as ever to reduce the spread of COVID-19 and its variants.

SOURCE Public Health Agency of Canada

These press releases may also interest you

at 02:10
Southern Energy Corp. ("Southern" or the "Company") (SOU:TSXV) (AIM:SOUC) announces the spudding of its three Selma Chalk horizontal wells in the Gwinville field targeting natural gas. The three wells will be drilled from the same...

at 02:05
Cross-Border Commerce Europe, the platform driving cross-border e-commerce in Europe, publishes its latest blue paper summarising the learnings of seven knowledge and brainstorming sessions between C-Level executives from leading global retailers...

at 02:00
The latest e-learning market in Europe report by Technavio infers that the growing emphasis on personalized learning is driving this market's growth....

at 02:00
Puxin Limited ("Puxin" or the "Company"), today announced that it will change the effective date of its change to the ratio of its American depositary shares ("ADSs"). On January 21, 2022, Puxin announced that it intended to change the ratio of its...

at 01:35
RELIEF THERAPEUTICS Holding SA (SIX:RLF) ("Relief"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, reported today that the parent company, NRx Pharmaceuticals, Inc....

at 01:17
BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL inhibitors for severe unmet medical needs and Oslo University Hospital announced today the execution of a collaborative agreement to study the...

News published on 28 november 2021 at 17:08 and distributed by: